In the realm of antimicrobials, macrolides stand out as a versatile class of antibiotics with a broad spectrum of activity. These drugs are characterized by their complex structure, consisting of a large macrocyclic lactone ring. This unique structure contributes to their ability to combat a diverse range of bacterial infections. Erythromycin, the prototypical macrolide, paved the way for subsequent derivatives like azithromycin and clarithromycin. Their mechanism of action involves binding to the bacterial ribosome, inhibiting protein synthesis. This interference disrupts the normal functioning of bacteria, leading to their inhibition or destruction. Macrolides find application in the treatment of respiratory tract infections, skin and soft tissue infections, and certain atypical bacterial infections. Azithromycin, in particular, is well-regarded for its wide tissue distribution and prolonged action, allowing for shorter treatment courses. While macrolides are generally well-tolerated, they are not immune to adverse effects. Gastrointestinal symptoms, liver enzyme abnormalities, and potential interactions with other medications should be considered when prescribing these antibiotics. As with any antimicrobial, prudent use and awareness of potential side effects are crucial for optimizing patient outcomes.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation